{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T10:57:57Z","timestamp":1775127477282,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82271427"],"award-info":[{"award-number":["82271427"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"crossref","award":["2022YFC3602802"],"award-info":[{"award-number":["2022YFC3602802"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific Research Foundation of China Rehabilitation Research Center","award":["2022ZX-08"],"award-info":[{"award-number":["2022ZX-08"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-40289-w","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T03:23:18Z","timestamp":1772076198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pramipexole alleviates ferroptosis in HT22 cells induced by oxygen\u2013glucose deprivation\/reoxygenation via the Nrf2\/SLC7A11\/GPX4 pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Linyao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianhui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zijie","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruixin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"issue":"12","key":"40289_CR1","doi-asserted-by":"publisher","first-page":"e897","DOI":"10.1016\/S2468-2667(21)00228-0","volume":"6","author":"Q Ma","year":"2021","unstructured":"Ma, Q. et al. Temporal trend and attributable risk factors of stroke burden in China, 1990-2019: An analysis for the Global Burden of Disease Study 2019. Lancet Public Health 6(12), e897\u2013e906 (2021).","journal-title":"Lancet Public Health"},{"issue":"8","key":"40289_CR2","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/CIR.0000000000001303","volume":"151","author":"SS Martin","year":"2025","unstructured":"Martin, S. S. et al. 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association[J]. Circulation 151(8), e41\u2013e660 (2025).","journal-title":"Circulation"},{"issue":"2","key":"40289_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3171\/jns.1992.77.2.0169","volume":"77","author":"BK Siesj\u00f6","year":"1992","unstructured":"Siesj\u00f6, B. K. Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology[J]. J. Neurosurg. 77(2), 169\u2013184 (1992).","journal-title":"J. Neurosurg."},{"issue":"1","key":"40289_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/j.2040-4603.2017.tb00741.x","volume":"7","author":"T Kalogeris","year":"2016","unstructured":"Kalogeris, T., Baines, C. P., Krenz, M. & Korthuis, R. Ischemia\/Reperfusion. Compr. Physiol. 7(1), 113\u2013170 (2016).","journal-title":"Compr. Physiol."},{"issue":"7","key":"40289_CR5","volume":"54","author":"P Zhou","year":"2021","unstructured":"Zhou, P., Luo, K. & Shi, Y. Research progress on ferroptosis signaling pathways in ischemic brain injury. Chin. J. Neurol. 54(7), 6 (2021).","journal-title":"Chin. J. Neurol."},{"key":"40289_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2023.114541","volume":"369","author":"H Liu","year":"2023","unstructured":"Liu, H. et al. Rhein attenuates cerebral ischemia-reperfusion injury via inhibition of ferroptosis through NRF2\/SLC7A11\/GPX4 pathway. Exp. Neurol. 369, 114541 (2023).","journal-title":"Exp. Neurol."},{"key":"40289_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117438","volume":"321","author":"X Bai","year":"2024","unstructured":"Bai, X. et al. Angong Niuhuang Wan inhibit ferroptosis on ischemic and hemorrhagic stroke by activating PPAR\u03b3\/AKT\/GPX4 pathway. J. Ethnopharmacol. 321, 117438 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"40289_CR8","first-page":"1","volume":"27","author":"W Yang","year":"2023","unstructured":"Yang, W. et al. Exosomes from young healthy human plasma promote functional recovery from intracerebral hemorrhage via counteracting ferroptotic injury[J]. Bioact. Mater. 27, 1\u201314 (2023).","journal-title":"Bioact. Mater."},{"key":"40289_CR9","doi-asserted-by":"crossref","unstructured":"Yuan, Y., Zhai, Y., Chen, J., Xu, X., Wang, H. Kaempferol ameliorates oxygen-glucose deprivation\/reoxygenation-induced neuronal ferroptosis by activating Nrf2\/SLC7A11\/GPX4 axis. Biomolecules. 11(7) (2021).","DOI":"10.3390\/biom11070923"},{"key":"40289_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154112","volume":"102","author":"Q Hu","year":"2022","unstructured":"Hu, Q. et al. \u03b2-Caryophyllene suppresses ferroptosis induced by cerebral ischemia reperfusion via activation of the NRF2\/HO-1 signaling pathway in MCAO\/R rats[J]. Phytomedicine 102, 154112 (2022).","journal-title":"Phytomedicine"},{"key":"40289_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115021","volume":"289","author":"C Fu","year":"2022","unstructured":"Fu, C. et al. Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K\/AKT\/Nrf2 and SLC7A11\/GPX4 signaling pathway after ischemia. J. Ethnopharmacol. 289, 115021 (2022).","journal-title":"J. Ethnopharmacol."},{"issue":"17","key":"40289_CR12","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1021\/acschemneuro.0c00332","volume":"11","author":"SM Wilson","year":"2020","unstructured":"Wilson, S. M., Wurst, M. G., Whatley, M. F. & Daniels, R. N. Classics in chemical neuroscience: Pramipexole. ACS Chem. Neurosci. 11(17), 2506\u20132512 (2020).","journal-title":"ACS Chem. Neurosci."},{"issue":"05","key":"40289_CR13","first-page":"533","volume":"29","author":"X Kang","year":"2023","unstructured":"Kang, X., Liu, L., Wang, W. & Wang, Y. Effects of pramipexole combined with levodopa on cognitive function and mitochondrial function in rats with global cerebral ischemia-reperfusion injury. Chin. J. Rehabil. Theory Pract. 29(05), 533\u2013540 (2023).","journal-title":"Chin. J. Rehabil. Theory Pract."},{"issue":"1","key":"40289_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2024.108101","volume":"34","author":"X Kang","year":"2025","unstructured":"Kang, X. et al. Dopamine receptor agonist pramipexole exerts neuroprotection on global cerebral ischemia\/reperfusion injury by inhibiting ferroptosis. J. Stroke Cerebrovasc. Dis. 34(1), 108101 (2025).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"7","key":"40289_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17592","volume":"9","author":"K Xie","year":"2023","unstructured":"Xie, K., Mo, Y., Yue, E., Shi, N. & Liu, K. Exosomes derived from M2-type microglia ameliorate oxygen-glucose deprivation\/reoxygenation-induced HT22 cell injury by regulating miR-124-3p\/NCOA4-mediated ferroptosis. Heliyon 9(7), e17592 (2023).","journal-title":"Heliyon"},{"issue":"6","key":"40289_CR16","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1021\/acscentsci.0c01592","volume":"7","author":"Y Fang","year":"2021","unstructured":"Fang, Y. et al. Inhibiting ferroptosis through disrupting the NCOA4-FTH1 interaction: A new mechanism of action. ACS Cent. Sci. 7(6), 980\u2013989 (2021).","journal-title":"ACS Cent. Sci."},{"issue":"11","key":"40289_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2012.171","volume":"3","author":"A Perelman","year":"2012","unstructured":"Perelman, A. et al. JC-1: Alternative excitation wavelengths facilitate mitochondrial membrane potential cytometry. Cell Death Dis. 3(11), e430 (2012).","journal-title":"Cell Death Dis."},{"issue":"3 Suppl 1","key":"40289_CR18","first-page":"S149","volume":"44","author":"E Melamed","year":"1998","unstructured":"Melamed, E. et al. Levodopa toxicity and apoptosis. Ann. Neurol. 44(3 Suppl 1), S149\u2013S154 (1998).","journal-title":"Ann. Neurol."},{"issue":"9347","key":"40289_CR19","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/S0140-6736(02)11668-0","volume":"360","author":"CE Clarke","year":"2002","unstructured":"Clarke, C. E. & Guttman, M. Dopamine agonist monotherapy in Parkinson\u2019s disease. Lancet 360(9347), 1767\u20131769 (2002).","journal-title":"Lancet"},{"issue":"12","key":"40289_CR20","first-page":"1460","volume":"19","author":"CS Association","year":"2024","unstructured":"Association, C. S. & Stroke, W. G. O. C. Guidelines of the Chinese Stroke Association for Reperfusion Therapy in Acute Ischemic Stroke (2024)[J]. Chin. J. Stroke 19(12), 1460\u20131478 (2024).","journal-title":"Chin. J. Stroke"},{"issue":"1","key":"40289_CR21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1148\/radiology.168.1.3380958","volume":"168","author":"RB Dietrich","year":"1988","unstructured":"Dietrich, R. B. & Bradley, W. G. J. Iron accumulation in the basal ganglia following severe ischemic-anoxic insults in children. Radiology 168(1), 203\u2013206 (1988).","journal-title":"Radiology"},{"issue":"1","key":"40289_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.brainres.2003.10.051","volume":"997","author":"F Huang","year":"2004","unstructured":"Huang, F., Vemuri, M. C. & Schneider, J. S. Modulation of ATP levels alters the mode of hydrogen peroxide-induced cell death in primary cortical cultures: Effects of putative neuroprotective agents. Brain Res. 997(1), 79\u201388 (2004).","journal-title":"Brain Res."},{"issue":"6","key":"40289_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/0269905031000070279","volume":"17","author":"PD Patrick","year":"2003","unstructured":"Patrick, P. D., Buck, M. L., Conaway, M. R. & Blackman, J. A. The use of dopamine enhancing medications with children in low response states following brain injury. Brain Inj. 17(6), 497\u2013506 (2003).","journal-title":"Brain Inj."},{"key":"40289_CR24","first-page":"2069","volume":"29","author":"L Liu","year":"2006","unstructured":"Liu, L., Dong, W. & Shi, R. New approaches to clinical management of cerebral resuscitation. Chin. Med. J. 29, 2069\u20132071 (2006).","journal-title":"Chin. Med. J."},{"issue":"10","key":"40289_CR25","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/aps.2017.49","volume":"38","author":"Q Zhang","year":"2017","unstructured":"Zhang, Q. et al. Reassessment of subacute MPTP-treated mice as animal model of Parkinson\u2019s disease[J]. Acta Pharmacol. Sin. 38(10), 1317\u20131328 (2017).","journal-title":"Acta Pharmacol. Sin."},{"key":"40289_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2022.136911","volume":"791","author":"C Liu","year":"2022","unstructured":"Liu, C. et al. Pramipexole alleviates traumatic brain injury in rats through inhibiting necroptosis[J]. Neurosci. Lett. 791, 136911 (2022).","journal-title":"Neurosci. Lett."},{"issue":"1-2","key":"40289_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0006-8993(96)00968-7","volume":"742","author":"ED Hall","year":"1996","unstructured":"Hall, E. D., Andrus, P. K., Oostveen, J. A., Althaus, J. S. & VonVoigtlander, P. F. Neuroprotective effects of the dopamine D2\/D3 agonist pramipexole against postischemic or methamphetamine-induced degeneration of nigrostriatal neurons. Brain Res. 742(1\u20132), 80\u201388 (1996).","journal-title":"Brain Res."},{"issue":"12","key":"40289_CR28","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1007\/s11064-022-03789-5","volume":"47","author":"H Yang","year":"2022","unstructured":"Yang, H. et al. Cerebral ischemia\/reperfusion injury and pharmacologic preconditioning as a means to reduce stroke-induced inflammation and damage. Neurochem. Res. 47(12), 3598\u20133614 (2022).","journal-title":"Neurochem. Res."},{"issue":"1","key":"40289_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01862-x","volume":"21","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Anti-CHAC1 exosomes for nose-to-brain delivery of miR-760-3p in cerebral ischemia\/reperfusion injury mice inhibiting neuron ferroptosis. J. Nanobiotechnology 21(1), 109 (2023).","journal-title":"J. Nanobiotechnology"},{"key":"40289_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107389","volume":"208","author":"P Thapak","year":"2024","unstructured":"Thapak, P. & Gomez-Pinilla, F. The bioenergetics of traumatic brain injury and its long-term impact for brain plasticity and function. Pharmacol. Res. 208, 107389 (2024).","journal-title":"Pharmacol. Res."},{"issue":"9","key":"40289_CR31","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1161\/STROKEAHA.118.021179","volume":"49","author":"Y Zhao","year":"2018","unstructured":"Zhao, Y. et al. Synergistic interaction between zinc and reactive oxygen species amplifies ischemic brain injury in rats[J]. Stroke 49(9), 2200\u20132210 (2018).","journal-title":"Stroke"},{"key":"40289_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2022.110137","volume":"366","author":"M Li","year":"2022","unstructured":"Li, M. et al. Baicalein ameliorates cerebral ischemia-reperfusion injury by inhibiting ferroptosis via regulating GPX4\/ACSL4\/ACSL3 axis. Chem. Biol. Interact. 366, 110137 (2022).","journal-title":"Chem. Biol. Interact."},{"issue":"9","key":"40289_CR33","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.7150\/ijbs.83348","volume":"19","author":"J Li","year":"2023","unstructured":"Li, J. et al. The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks. Int. J. Biol. Sci. 19(9), 2756\u20132771 (2023).","journal-title":"Int. J. Biol. Sci."},{"key":"40289_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103406","volume":"77","author":"X Lan","year":"2024","unstructured":"Lan, X. et al. Isoliquiritigenin alleviates cerebral ischemia-reperfusion injury by reducing oxidative stress and ameliorating mitochondrial dysfunction via activating the Nrf2 pathway[J]. Redox Biol. 77, 103406 (2024).","journal-title":"Redox Biol."},{"key":"40289_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2019.101107","volume":"23","author":"M Dodson","year":"2019","unstructured":"Dodson, M., Castro-Portuguez, R. & Zhang, D. D. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 23, 101107 (2019).","journal-title":"Redox Biol."},{"issue":"1","key":"40289_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56344-5","volume":"16","author":"B Huang","year":"2025","unstructured":"Huang, B. et al. Palmitoylation-dependent regulation of GPX4 suppresses ferroptosis. Nat. Commun. 16(1), 867 (2025).","journal-title":"Nat. Commun."},{"issue":"1","key":"40289_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03099-3","volume":"21","author":"J Chen","year":"2024","unstructured":"Chen, J. et al. Oroxin A alleviates early brain injury after subarachnoid hemorrhage by regulating ferroptosis and neuroinflammation. J. Neuroinflammation 21(1), 116 (2024).","journal-title":"J. Neuroinflammation"},{"key":"40289_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154962","volume":"118","author":"X Li","year":"2023","unstructured":"Li, X. et al. Berberine ameliorates iron levels and ferroptosis in the brain of 3\u00a0\u00d7\u00a0Tg-AD mice. Phytomedicine 118, 154962 (2023).","journal-title":"Phytomedicine"},{"issue":"11","key":"40289_CR39","doi-asserted-by":"publisher","first-page":"3558","DOI":"10.7150\/ijbs.85454","volume":"19","author":"X Wang","year":"2023","unstructured":"Wang, X., Kong, X., Feng, X. & Jiang, D. Effects of DNA, RNA, and protein methylation on the regulation of ferroptosis. Int. J. Biol. Sci. 19(11), 3558\u20133575 (2023).","journal-title":"Int. J. Biol. Sci."},{"issue":"8","key":"40289_CR40","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula, P., Zhuang, L. & Gan, B. Cystine transporter SLC7A11\/xCT in cancer: Ferroptosis, nutrient dependency, and cancer therapy. Protein Cell 12(8), 599\u2013620 (2021).","journal-title":"Protein Cell"},{"issue":"1","key":"40289_CR41","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.12332","volume":"21","author":"Y Iida","year":"2021","unstructured":"Iida, Y. et al. Effective ferroptotic small-cell lung cancer cell death from SLC7A11 inhibition by sulforaphane. Oncol. Lett. 21(1), 71 (2021).","journal-title":"Oncol. Lett."},{"issue":"2","key":"40289_CR42","first-page":"19","volume":"59","author":"TI Kmet","year":"2015","unstructured":"Kmet, T. I. & Tkachuk, S. S. [Dynamics of changes of p53-positive cells morphofunctional condition in the cerebral cortex of the temporal lobe in rats affected by carotid ischemia-reperfusion]. Patol. Fiziol. Eksp. Ter. 59(2), 19\u201322 (2015).","journal-title":"Patol. Fiziol. Eksp. Ter."},{"key":"40289_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118721","volume":"336","author":"J Shang","year":"2025","unstructured":"Shang, J. et al. Naoxintong capsule accelerates mitophagy in cerebral ischemia-reperfusion injury via TP53\/PINK1\/PRKN pathway based on network pharmacology analysis and experimental validation. J. Ethnopharmacol. 336, 118721 (2025).","journal-title":"J. Ethnopharmacol."},{"key":"40289_CR44","doi-asserted-by":"crossref","unstructured":"Rochette, L., Dogon, G., Rigal, E., Zeller, M., Cottin, Y., Vergely, C. Lipid peroxidation and iron metabolism: Two corner stones in the homeostasis control of ferroptosis. Int. J. Mol. Sci. 24(1) (2022).","DOI":"10.3390\/ijms24010449"},{"issue":"1","key":"40289_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01969-z","volume":"9","author":"Q Ru","year":"2024","unstructured":"Ru, Q. et al. Iron homeostasis and ferroptosis in human diseases: Mechanisms and therapeutic prospects. Signal Transduct. Target. Ther. 9(1), 271 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"40289_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2023.1191629","volume":"17","author":"R She","year":"2023","unstructured":"She, R. et al. Mitochondrial dysfunctions induce PANoptosis and ferroptosis in cerebral ischemia\/reperfusion injury: From pathology to therapeutic potential. Front. Cell Neurosci. 17, 1191629 (2023).","journal-title":"Front. Cell Neurosci."},{"key":"40289_CR47","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.freeradbiomed.2018.05.074","volume":"133","author":"R Kang","year":"2019","unstructured":"Kang, R., Kroemer, G. & Tang, D. The tumor suppressor protein p53 and the ferroptosis network. Free Radic. Biol. Med. 133, 162\u2013168 (2019).","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"40289_CR48","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41401-022-00951-1","volume":"44","author":"A Dong","year":"2023","unstructured":"Dong, A. et al. Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson\u2019s disease. Acta Pharmacol. Sin. 44(1), 32\u201343 (2023).","journal-title":"Acta Pharmacol. Sin."},{"issue":"11","key":"40289_CR49","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.5664\/jcsm.3174","volume":"9","author":"AV Salminen","year":"2013","unstructured":"Salminen, A. V. et al. Disconnection between periodic leg movements and cortical arousals in spinal cord injury. J. Clin. Sleep Med. 9(11), 1207\u20131209 (2013).","journal-title":"J. Clin. Sleep Med."},{"issue":"3","key":"40289_CR50","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41418-017-0012-4","volume":"25","author":"L Galluzzi","year":"2018","unstructured":"Galluzzi, L. et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018[J]. Cell Death Differ. 25(3), 486\u2013541 (2018).","journal-title":"Cell Death Differ."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40289-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40289-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40289-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T10:02:41Z","timestamp":1775124161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40289-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["40289"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-40289-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"assertion":[{"value":"21 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The cell line used in this study (\n                      HT22\n                      ) was purchased from the Guangzhou Jiniou Biotechnology Co., Ltd. and is commercially available and de-identified. The study only involved in vitro cell culture and did not include any in vivo animal experiments or human clinical trials. According to the regulations of our institution\u2019s ethics committee, studies using commercialized, non-primary cell lines do not require additional animal or human ethics approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"11134"}}